Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials click here
Thursday, February 7, 2013
Chronic Hepatitis Cohort Study Sheds Light on Burden of Hepatitis B and C in U.S.
Over years or decades chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection can lead to advanced liver disease including cirrhosis (scarring) and hepatocellular carcinoma. Hepatitis B can be prevented with an effective vaccine, but complete cures are uncommon. Hepatitis C, in contrast, currently has no vaccine but treatment is increasingly effective at curing infection.
Read more here...